Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for FENTANYL CITRATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Labeling changes approved for HOSPIRA. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 36
  • 0 comments

Labeling changes approved for MIKART. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 31
  • 0 comments

Labeling changes approved for AMNEAL PHARMS NY. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Comment Full text

FDA expands indications for MOUNJARO

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 35
  • 0 comments

ELI LILLY AND CO receives approval for new indications. Submission: SUPPL-39. Decision date: 12/19/2025

Comment Full text

FDA updates labeling for PERCODAN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 24
  • 0 comments

Labeling changes approved for ENDO OPERATIONS. Active ingredient: ASPIRIN; OXYCODONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for HYCODAN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 29
  • 0 comments

Labeling changes approved for GENUS. Active ingredient: HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACTIQ

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 25
  • 0 comments

Labeling changes approved for CEPHALON. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for DEMEROL

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 24
  • 0 comments

Labeling changes approved for HOSPIRA. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for NUCYNTA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 34
  • 0 comments

Labeling changes approved for COLLEGIUM PHARM INC. Active ingredient: TAPENTADOL HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MEPERIDINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 26
  • 0 comments

Labeling changes approved for GENUS. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text
  • Previous
  • 24
  • 25
  • 26
  • 27
  • 28
  • Next

Search

News categories

  • Technical Exchange News(12106)
  • Event(5417)
  • SEC News(252461)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150797)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin